Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

YMAB

Y-mAbs Therapeutics, Inc.

Healthcare

Set alert

Price alert · YMAB

All alert types
8.61 0.00 0.00%
As of Sep 16, 2025
8.61 Day range 8.61
6.48 52-week range 20.90
Open
8.61
Prev close
8.61
Mkt cap
363.24M
Vol
760.67K
Avg vol
249.12K
EPS
-0.54
P/E
0.00
Div yield
0.00%
More statistics
Low
8.61
High
8.61
Forward P/E
-13.98
Beta
0.67
Short ratio
13.91
Inst. own
72.19%
Dividend
0.00
Ex-div date
Earnings
Aug 12, 2024
50-d avg
12.41
200-d avg
13.15
1y target
20.64

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for YMAB has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.77 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -11.7×
FY 2016: -24.7×FY 2017: -41.4×FY 2018: -13.6×FY 2019: -14.0×FY 2020: -16.7×FY 2021: -12.7×FY 2022: -2.2×FY 2023: -13.9×FY 2024: -11.7×
FY 2016 5y median -12.7× FY 2024
P/S 4.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 95.7×FY 2021: 20.1×FY 2022: 3.3×FY 2023: 3.5×FY 2024: 4.0×
FY 2016 5y median 4.0× FY 2024
P/B 3.8×
FY 2016: 35.1×FY 2017: 9.7×FY 2018: 4.2×FY 2019: 5.5×FY 2020: 18.8×FY 2021: 3.9×FY 2022: 2.0×FY 2023: 2.9×FY 2024: 3.8×
FY 2016 5y median 3.8× FY 2024
P/FCF -22.1×
FY 2016: -37.9×FY 2017: -50.3×FY 2018: -14.1×FY 2019: -14.6×FY 2020: -21.7×FY 2021: -6.8×FY 2022: -2.8×FY 2023: -10.9×FY 2024: -22.1×
FY 2016 5y median -10.9× FY 2024
EV/EBITDA -9.2×
FY 2016: -22589×FY 2017: 8537×FY 2018: -10.1×FY 2019: -10.8×FY 2020: -15.7×FY 2021: -9.6×FY 2022: -1.2×FY 2023: -8.8×FY 2024: -9.2×
FY 2016 5y median -9.2× FY 2024
EV/Sales 3.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 90.4×FY 2021: 15.0×FY 2022: 1.7×FY 2023: 2.6×FY 2024: 3.2×
FY 2016 5y median 3.2× FY 2024
FCF Yield -4.5%
FY 2016: -2.6%FY 2017: -2.0%FY 2018: -7.1%FY 2019: -6.9%FY 2020: -4.6%FY 2021: -14.8%FY 2022: -35.6%FY 2023: -9.1%FY 2024: -4.5%
FY 2016 5y median -9.1% FY 2024

Profitability

Gross Margin 82.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 89.4%FY 2021: 92.8%FY 2022: 88.4%FY 2023: 86.5%FY 2024: 82.6%
FY 2016 5y median 88.4% FY 2024
Operating Margin -35.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -578.0%FY 2021: -330.8%FY 2022: -145.3%FY 2023: -30.3%FY 2024: -35.6%
FY 2016 5y median -145.3% FY 2024
Net Margin -33.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -575.1%FY 2021: -158.4%FY 2022: -146.4%FY 2023: -25.3%FY 2024: -33.8%
FY 2016 5y median -146.4% FY 2024
ROE -32.2%
FY 2016: -141.4%FY 2017: -23.3%FY 2018: -30.8%FY 2019: -39.7%FY 2020: -112.8%FY 2021: -30.7%FY 2022: -87.5%FY 2023: -21.2%FY 2024: -32.2%
FY 2016 5y median -32.2% FY 2024
ROIC -32.1%
FY 2016: -119.3%FY 2017: -22.9%FY 2018: -30.2%FY 2019: -40.8%FY 2020: -104.8%FY 2021: -61.8%FY 2022: -83.1%FY 2023: -23.6%FY 2024: -32.1%
FY 2016 5y median -61.8% FY 2024
ROA -24.7%
FY 2016: -98.8%FY 2017: -20.8%FY 2018: -28.5%FY 2019: -36.5%FY 2020: -90.4%FY 2021: -26.0%FY 2022: -67.6%FY 2023: -16.8%FY 2024: -24.7%
FY 2016 5y median -26.0% FY 2024

Growth (YoY)

Revenue 3.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 68.2%FY 2022: 87.0%FY 2023: 30.0%FY 2024: 3.4%
FY 2016 FY 2024
Operating Income -21.5%
FY 2016: 0.0%FY 2017: -12.9%FY 2018: -124.6%FY 2019: -92.0%FY 2020: -44.5%FY 2021: 3.8%FY 2022: 17.9%FY 2023: 72.9%FY 2024: -21.5%
FY 2016 FY 2024
EPS (diluted) -36.7%
FY 2016: 0.0%FY 2017: 40.2%FY 2018: -158.6%FY 2019: -49.3%FY 2020: -32.6%FY 2021: 56.9%FY 2022: -71.9%FY 2023: 77.7%FY 2024: -36.7%
FY 2016 FY 2024
Free Cash Flow 42.3%
FY 2016: 0.0%FY 2017: -42.1%FY 2018: -161.3%FY 2019: -82.0%FY 2020: -21.1%FY 2021: -13.3%FY 2022: 26.7%FY 2023: 64.1%FY 2024: 42.3%
FY 2016 FY 2024

Financial Health

Current Ratio 4.2×
FY 2016: 5.8×FY 2017: 11.5×FY 2018: 16.6×FY 2019: 15.6×FY 2020: 6.3×FY 2021: 7.3×FY 2022: 4.6×FY 2023: 5.5×FY 2024: 4.2×
FY 2016 5y median 5.5× FY 2024
Quick Ratio 3.9×
FY 2016: 5.8×FY 2017: 11.5×FY 2018: 16.6×FY 2019: 15.6×FY 2020: 6.3×FY 2021: 7.1×FY 2022: 4.4×FY 2023: 5.3×FY 2024: 3.9×
FY 2016 5y median 5.3× FY 2024
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2016 5y median 0.0× FY 2024
Net Debt / EBITDA 2.2×
FY 2016: 938×FY 2017: -1090×FY 2018: 3.4×FY 2019: 2.5×FY 2020: 0.9×FY 2021: 3.3×FY 2022: 1.1×FY 2023: 3.1×FY 2024: 2.2×
FY 2016 5y median 2.2× FY 2024
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -42.0×FY 2020: 0.0×FY 2021: -62.3×FY 2022: -125×FY 2023: 0.0×FY 2024: 0.0×
FY 2016 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2016 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2016 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31